Strotay Life Sciences (P) Ltd. Mumbai, Maharashtra

We are one of the leading Bambuterol drugs suppliers in India. We have a wide range of bambuterol capsules which are completely safe and can nourish your body needs. These bambuterol capsules are manufactured as per WHO standards! PRO-T (Bambuterol) is a Long acting beta-adrenoceptor agonist. Long acting beta-adrenoceptor agonists are usually prescribed for moderate to severe persistent asthma patients or patients with COPD. They are designed to replace the shorter acting B2-agonists such as salbutamol, as they have a duration of action of approximately 15-24 hours in comparison with the 4-6 hour duration of salbutamol, making them ideal candidates for once daily administration. PRO-T (bambuterol) is an oral long-acting beta2-agonist for once-daily treatment of the symptoms of asthma, particularly in patients who are unable to use inhaled products (such as children and the elderly). It is supplied as tablets and as a liquid medicine. PRO-T is a pro-drug that it is slowly converted in the body to the active form, thus providing a prolonged action. Bambuterol or PRO-T is the pro drug of the beta agonist terbutaline. This means that once Bambuterol or PRO-T is in the body it is changed to terbutaline. The drug then acts directly on the alveoli in the lungs to open them up and make breathing easier. It is relatively long acting - 24 hours, thus can be used to prevent asthma symptoms occurring during the night and improve sleep quality. Bambuterol or PRO-T side effects are most often mild - headache, nausea, fatigue, palpitations, dizziness, and tremor, however there are reports of having to stop taking the drug where dizziness was marked. The frequency of side effects usually diminishes with time. Because Bambuterol or PRO-T is an oral tablet, people who cannot use inhalers may find it useful. People who have cardiovascular conditions should use Bambuterol or PRO-T carefully.

We can reorganize the needs of health conscious clients and catering them the most nutritious range of Pantoprazole tablets. Moreover we have an intricate spectrum of pharmaceutical pantoprazole that are safe and risk free. Our pharmaceutical pantoprazole has been approved by the international medical experts! In addition, we are the allegiant pantoprazole suppliers of India. PANTOZE (Pantoprazole) is used to treat gastroesophageal reflux disease (GERD), a condition in which backward flow of acid from the stomach causes heartburn and injury of the food pipe (esophagus). It is also used to treat conditions where the stomach produces too much acid, such as Zollinger-Ellison syndrome. Pantoprazole is in a class of medications called proton-pump inhibitors. It works by decreasing the amount of acid made in the stomach. This medicine may be prescribed for other uses; ask your doctor or pharmacist for more information. PANTOZE (Pantoprazole) is metabolized in the liver by the cytochrome P450 system. Metabolism mainly consists of demethylation by CYP2C19 followed by sulfation. Another metabolic pathway is oxidation by CYP3A4. Pantoprazole metabolites are not thought to have any pharmacological significance. Pantoprazole is relatively free of drug interactions. The active ingredient in PANTOZE (pantoprazole sodium) is a substituted benzimidazole, sodium 5-(difluoromethoxy)-2-[[(3, 4-dimethoxy-2-pyridinyl)methyl] sulfinyl]-1H-benzimidazole sesquihydrate, a compound that inhibits gastric acid secretion. Its empirical formula is C16H14F2N3NaO4S x 1.5 H2O, with a molecular weight of 432.4. PANTOZE (pantoprazole) is supplied in 2 strengths (40 mg and 20 mg); and as delayed-release granules for oral administration, available in the 40 mg strength. PANTOZE (pantoprazole) is also available in dry injection form. Pantoprazole is having maximum market share amongst all other used PPI (Proton pump inhibitors) in the market.

We have carned a niche as one of the trusted Suppliers of Etoricoxib in India. Oral Etoricoxib is at least as effective as other drugs commonly used for pain relief after surgery. A Cochrane Systematic Review has confirmed the effectiveness of the drug, which is sold under the brand name of Arcoxia. Developed as an alternative to conventional non-steroidal anti-inflammatory drugs (NSAIDs), which can cause intestinal bleeding, "coxibs� are licensed for chronic and acute pain. In primary care in England, 64, 000 prescriptions for the highest Etoricoxib dose (120 mg) were issued in 2007. Five studies with 880 participants were included in the review. Four followed patients experiencing pain due to tooth extractions. The fifth focused on patients with pain following orthopaedic surgery. For two thirds of patients etoricoxib provided effective pain relief for 20 hours, compared to one in ten patients for just two hours with a placebo. "Single dose Oral Etoricoxib Drug produces high levels of good quality pain relief after surgery, " says lead researcher Andrew Moore, of the Pain Research and Nuffield Department of Anaesthetics at the University of Oxford. Moore adds that the long lasting action of Etoricoxib Medicine makes it qualitatively different from other coxibs and ibuprofen. "We have effective analgesics, but often fail to deliver them effectively. A longer time before remedication is likely to benefit patients by providing long-lasting pain relief, and reduce demands on nursing staff, " he says. Sheena Derry, another author, comments, "Acute pain studies like these have been done for over 60 years, using similar patients, similar methods, and the same outcomes. This is just one of a series of new reviews and updates in acute pain aiming to cover one whole section of the British National Formulary. The end product should help providers construct consistent and effective ways of delivering good pain relief to patients."